Volume 11, Number 6—June 2005
Research
Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States
Matthew J. Kuehnert*, Holly A. Hill*, Benjamin A. Kupronis*, Jerome I. Tokars*, Steven L. Solomon*, and Daniel B. Jernigan*
Table 3
Staphylococcus aureus–related hospitalizations, United States, 1999–2000, by patient age*
| Age (y) | Discharge diagnosis |
||||
|---|---|---|---|---|---|
| S. aureus (%) | S. aureus rate† | MR (%) | MRSA rate† | MRSA RR (95% CI) | |
| <14 | 6.7 | 8.08 | 16.2 | 1.31 | Referent |
| 15–44 | 19.6 | 5.69 | 29.3 | 1.67 | 1.2 (0.94–1.6) |
| 45–64 | 23.1 | 9.74 | 39.1 | 3.81 | 2.9 (2.2–3.8) |
| >65 | 50.6 | 11.76 | 54.1 | 6.36 | 4.8 (3.7–6.2) |
*MR, methicillin resistant; MRSA, methicillin-resistant S. aureus; RR, relative risk; CI, confidence interval.
†Rate, hospitalizations with S. aureus or MRSA-related discharge diagnoses per 10,000 discharges.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.